ClinicalTrials.gov
public full text
Public Domain
Shiatsu Adjuvant Therapy For Schizophrenia
In the current study we will study the effect of adding shiatsu treatment to conventional therapy in work with hospitalized schizophrenic patients. The hypotheses of this study are several: 1. Shiatsu can improve the patients' symptoms 2. Shiatsu can ameliorate neuromuscular side effects produced by standard anti-psychotic treatment 3. Shiatsu can provide patients with tools to deal with the stresses of their illness 2\. Methodology We propose an open pilot study in which a total of 20 patients of both sexes will be enrolled. These patients will be drawn from the inpatient psychiatric wards at Herzog Hospital. Upon inclusion into the trial, all participants will receive shiatsu treatment, consisting of two individual weekly 40-minute shiatsu treatment sessions for four weeks. Provider and patient will be of the same gender. Standard pharmacotherapy will be provided as needed during the treatment period. Medication and dosage will not be changed. If necessary, benzodiazepines will be administered as required. Outcome measures: The following assessments will be included: 1. Medication: Use of SOS benzodiazepines 2. Clinical rating scales: PANSS, CGI, NOSIE, Hamilton Scales for depression and anxiety 1\. Side effect scales: Simpson Angus Scale, AIMS scale, UKU scale 2. Neurophysiological testing: Prepulse inhibition (PPI). 3. Neurocognitive testing: This will be performed using the NIMH's Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) Consensus Cognitive Battery for Clinical Trials.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression#907574
- The OBSERVE Protocol#1113958
- A Study of the Efficacy and Safety of Asenapine in Participants With an Acute Exacerbation of Schizophrenia (P05688)#1073278
- CAMHS and Social Prescribing Applications#825502
- Combined Mirtazapine and SSRI Treatment of PTSD: A Placebo-Controlled Trial#969273
Record · ID 1197514
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive